The State Food and Drug Administration approved the promulgation of the first batch of national standards for Chinese medicine formula granules

On April 29, the official website of the State Food and Drug Administration announced that, on the basis of the preliminary work, the State Pharmacopoeia Commission organized the National Pharmacopoeia Commission to carry out relevant procedures in accordance with the "Technical Requirements for the Quality Control and Standard Establishment of Chinese Medicine Formula Granules" and the national drug standards.

After standard research and drafting, production verification, standard review, professional committee review, public opinion solicitation, review, etc.

The national standard of traditional Chinese medicine formula granules fully embodies the quality control characteristics of traditional Chinese medicine and the concept of full quality control.

After the promulgation of the first batch of Chinese medicine formula granules national standards, a transition period of 6 months will be set up and will be officially implemented on November 1, 2021.

During the implementation of the standards, the manufacturers further accumulate data and submit them to the National Pharmacopoeia Commission to gradually improve and raise the standards.